SAIK ANDREW (EVP & Chief Financial Officer) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/23/2023ACC: 0001104659-23-036043
Officer· EVP & Chief Financial Officer
Since Jun 2021
-909.00
Net shares
Net seller
$12.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
909.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−909.00
Price / share
$14.19
Trade value
$12.90K
% of position
1.3%
3/21/2023
70.99K→70.08K
Total
Net shares
−909.00
Net value
-$12.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/21/2023 | F · Tax Withholding | −909.00 | $14.19 | $12.90K | 1.3% | 70.99K | 70.08K |
| Total | −909.00 | -$12.90K | ||||||
Derivative Transactions0
No derivative transactions reported